Empowering Research: Lightcast Discovery Secures $49M To Unveil Single-Cell Functional Analysis Platform

Aug 18, 2023•almost 2 years ago

Amount Raised

$49 Million

CambridgeBiotechnology

Investors

Longwall Ventures+Nd CapitalOmx VenturesIllumina VenturesArch Venture PartnersM Ventures

Description

UK-based Lightcast Discovery is a biotech company developing a novel single-cell functional analysis platform. Now, the company has completed its Series B funding round by raising £38 million. The investment round was led by M Ventures and saw participation from existing investors ARCH Venture Partners, Illumina Ventures, OMX Ventures, +ND Capital and Longwall Ventures, known for its investments in Wayland Additive.

Company Information

Company

Lightcast Discovery

Location

Cambridge, Massachusetts, United States

About

Lightcast is developing a novel, droplet-based platform that provides a deeper understanding of cellular function. Compared to standard microfluidic methods, the Lightcast platform offers the ability to run a broader range of assays and to precisely control and track the number, occupancy, location, and movement of each droplet. The unprecedented scalability and flexibility of this approach will help advance translational and basic research as well as streamline development workflows for drugs, therapeutics, and applied biologics.

Related People

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends